Reference number : 236-2011-2012-Q1-00908, amendment number : , agreement type : G, recipient legal name : SAHEBJAM, Solmaz, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5S 1A1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 55000.0, agreement start date : 2011-08-01, agreement end date : 2013-07-31, description english : Evaluating the anti-tumor activity of a dual IGF-1R and IR inhibitor (OSI-906) in genomically characterized human breast cancer (BC) xenograft models., description french : Evaluating the anti-tumor activity of a dual IGF-1R and IR inhibitor (OSI-906) in genomically characterized human breast cancer (BC) xenograft models., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2013-14)

Start date may be subject to change.  Funding for awards must commence within 12 months of the date of offer., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2013-14)

La date de début peut être sujet au changement.  Le financement des bourses doit commencer dans les 12 mois suivant la date à laquelle elles ont été offertes., owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada